The DOI matches its Crossref record.
IgG4-Related Systemic Disease: Features and Treatment Response in a French Cohort Results of a Multicenter Registry
Abstract
IgG4-related systemic disease is now recognized as a systemic disease that may affect various organs. The diagnosis is usually made in patients who present with elevated IgG4 in serum and tissue infiltration of diseased organs by numerous IgG4+ plasma cells, in the absence of validated diagnosis criteria. We report the clinical, laboratory, and histologic characteristics of 25 patients from a French nationwide cohort. We also report the treatment outcome and show that despite the efficacy of corticosteroids, a second-line treatment is frequently necessary. The clinical findings in our patients are not different from the results of previous reports from Eastern countries. Our laboratory and histologic findings, however, suggest, at least in some patients, a more broad polyclonal B cell activation than the skewed IgG4 switch previously reported. These observations strongly suggest the implication of a T-cell dependent B-cell polyclonal activation in IgG4-related systemic disease, probably at least in part under the control of T helper follicular cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease
Khosroshahi, A., Wallace, Z. S., Crowe, J. L., Akamizu, T., Azumi, A., Carruthers, M. N., Chari, S. T., Della‐Torre, E., Frulloni, L., Goto, H., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39132 · Cited by 1,064
Self-citationIgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients
Wallace, Z. S., Deshpande, V., Mattoo, H., Mahajan, V. S., Kulikova, M., Pillai, S., & Stone, J. H. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39205 · Cited by 666
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
Wallace, Z. S., Mattoo, H., Carruthers, M., Mahajan, V. S., Della Torre, E., Lee, H., Kulikova, M., Deshpande, V., Pillai, S., & Stone, J. H. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205233 · Cited by 494
Rituximab for the Treatment of IgG4-Related Disease: Lessons From 10 Consecutive Patients
Khosroshahi, A., Carruthers, M. N., Deshpande, V., Unizony, S., Bloch, D. B., & Stone, J. H. (2012) · Medicine · doi:10.1097/md.0b013e3182431ef6 · Cited by 489
Advances in the diagnosis and management of IgG4 related disease
Lanzillotta, M., Mancuso, G., & Della-Torre, E. (2020) · BMJ · doi:10.1136/bmj.m1067 · Cited by 360
Metadata
- Authors
- Ebbo, M., Daniel, L., Pavic, M., Sève, P., Hamidou, M., Andres, E., Burtey, S., Chiche, L., Serratrice, J., Longy-Boursier, M., Ruivard, M., Haroche, J., Godeau, B., Beucher, A.-B., Berthelot, J.-M., Papo, T., Pennaforte, J.-L., Benyamine, A., Jourde, N., Landron, C., Roblot, P., Moranne, O., Silvain, C., Granel, B., Bernard, F., Veit, V., Mazodier, K., Bernit, E., Rousset, H., Boucraut, J., Boffa, J.-J., Weiller, P.-J., Kaplanski, G., Aucouturier, P., Harlé, J.-R., & Schleinitz, N.
- Venue
- Medicine
- Published
- 2012-01
- Volume
- 91
- Issue
- 1
- Pages
- 49-56
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W113269428
- Cited by
- 243
- References
- 0
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IgG4-Related Systemic Disease: Features and Treatment Response in a French Cohort Results of a Multicenter Registry. https://app.cochat.ai/papers/10.1097/md.0b013e3182433d77
- The paper
- Ebbo, M., Daniel, L., Pavic, M., Sève, P., Hamidou, M., Andres, E., Burtey, S., Chiche, L., Serratrice, J., Longy-Boursier, M., Ruivard, M., Haroche, J., Godeau, B., Beucher, A.-B., Berthelot, J.-M., Papo, T., Pennaforte, J.-L., Benyamine, A., Jourde, N., . . . Schleinitz, N. (2012). IgG4-Related Systemic Disease: Features and Treatment Response in a French Cohort Results of a Multicenter Registry. Medicine. https://doi.org/10.1097/md.0b013e3182433d77
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.